Skip to content

Antibacterial protease combined with silver dressing for the intervention of bacterial biofilm infection in chronic wounds

Antibacterial protease combined with silver dressing for the intervention of bacterial biofilm infection in chronic wounds

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019687
Enrollment
Unknown
Registered
2018-11-23
Start date
2017-06-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic wounds

Interventions

experimental group:Antibacterial protease

Sponsors

Drum Tower Hospital Affiliated to Nanjing University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Comply with the chronic wound diagnosis standard proposed by the Chinese Medical Association Trauma Branch in 2011 (ie, a wound that has not healed for more than one month and has no healing tendency); in the case of diabetes, blood glucose control is normal and stable in the past 2 weeks; (2) Comply with 6 clinical judgment standards in accordance with the existence of bacterial biofilm released in 2016: 1 wound bed with pale edema; 2 fragile granulation tissue; 3 large yellow exudate; 4 necrotic decay tissue; 5 wound pain; Have a rancid smell; (3) Aged at least 18 years old male and female; (4) Voluntarily participate in clinical research and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) accompanied by severe heart, lung, kidney and liver complications or critical illness, life-threatening conditions such as shock; (2) patients with bleeding disorders or bleeding tendency, patients with malignant tumors; organ transplant wounds; (3) Chronic wounds secondary to systemic infections or other infections requiring antibiotic treatment or antibiotics; (4) pregnant women or lactating women; combined with mental illness, can not cooperate; (5) The primary disease has an autoimmune disease or is taking hormones.

Design outcomes

Primary

MeasureTime frame
Reduction rate of wound volume;PUSH score;

Secondary

MeasureTime frame
temperature;PH;The bacterial extracellular matrix of wound and the decrease rate of bacteria;

Countries

China

Contacts

Public ContactWEI MIN

Nanjing University Medical School

824647903@qq.com+86 15850531741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026